// App-Quantinova.ai

: Bone marrow lesions are associated with pain, but not with inflammatory biomarkers in end-stage knee osteoarthritis patients

Researchers

Presenter

  • M.R. Radojcic

Principal Investigators

  • C.S. Thudium

  • K. Henriksen

  • K. Tan

  • R. Karlsten

  • A. Dudley

  • I. Chessell

  • M.A. Karsdal

  • A.-C. Bay-Jensen

  • M.D. Crema

  • A. Guermazi

Medical Centers

  • Nordic BioSci. Biomarkers & Res., Nordic BioSci. A/S, Herlev, Denmark

  • Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen Ø, Denmark

  • NeuroSci. Innovative Med.s, AstraZeneca, Cambridge, United Kingdom

  • Dept. of Surgical Sci., Anesthesiology and Intensive Care, Uppsala Univ., Uppsala, Sweden

  • Quantitative Imaging Ctr., Dept. of Radiology, Boston Univ. Sch. of Med., Boston, MA, USA

  • Dept. of Radiology, Hôpital Saint-Antoine, Univ. Paris VI, Paris, France

Locations

  • Denmark

  • United Kingdom

  • Sweden

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

  • Musculoskeletal

Disease

  • Knee osteoarthritis

  • Pain (neuropathic)

  • Osteoarthritis

  • Peritoneal colorectal carcinomatosis

Biomarkers

  • C reactive protein

  • High sensitivity C-reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved